Merck & Company (MRK) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $2.49
- Estimate
- $2.09
- Surprise
- +19.3%
- Score at report (before → after)
- 5.0 → 5.0/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
Merck & Company (MRK) beat the $2.09 estimate with adjusted EPS of $2.49 — a large 19.3% upside surprise. TrendMatrix's engine moved from Buy (Wait) (5.0/10) to Hold at 5.0/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates MRK Hold at 5.0/10.
4 of the last 4 quarters beat the estimate; this quarter's +19.3% surprise compares with a +20.8% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Analyst target reached - limited upside remaining
- Leverage penalty (D/E 1.3): -0.5
- Weak growth
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $146.33
- Stop
- $136.39
The stock trades at 116.1× trailing but 15.8× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-10-30 — shown for context, not personalized investment advice.
MRK at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Drug Manufacturers - General
- Market cap
- $361.02B
- P/E (fwd)
- 15.8
- P/E (ttm)
- 116.1
- 52-week range
- $82.01–$156.92
- Off 52-week high
- 6.7%
- RSI (14)
- 51
- Volume vs avg
- 1.32×
- Score today
- 5.0/10